SELARL PHARMACIE LEMAITRE MALCOTTI is a French company
founded 14 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in ALLAUCH (13190),
this company of category PME
shows in 2017 a revenue of 2.1 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELARL PHARMACIE LEMAITRE MALCOTTI (SIREN 533029039)
Indicator
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
2 055 505 €
2 161 090 €
Net income
127 744 €
70 373 €
113 469 €
118 276 €
134 466 €
164 149 €
132 382 €
118 181 €
119 102 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
220 919 €
234 241 €
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
5.7%
5.5%
Revenue and income statement
In 2024, SELARL PHARMACIE LEMAITRE MALCOTTI generates positive net income of 128 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 119 k€ -> 128 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
127 744 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 42%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 63%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
42.149%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
62.907%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Debt ratio
276.119
210.744
167.49
125.338
103.869
83.415
68.82
56.248
42.149
Financial autonomy
23.317
28.742
34.637
41.115
45.582
50.916
52.51
56.939
62.907
Repayment capacity
12.101
10.957
None
None
None
None
None
None
None
Cash flow / Revenue
6.878%
7.2%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
42.152024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Good-7 pts over 3 years
In 2024, the debt ratio of SELARL PHARMACIE LEMAITRE... (42.15) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
62.91%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Good+10 pts over 3 years
In 2024, the financial autonomy of SELARL PHARMACIE LEMAITRE... (62.9%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 93.96. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
106.426
97.064
97.105
115.048
159.209
154.913
124.052
106.453
93.956
Interest coverage
16.064
13.627
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
93.962024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Watch
In 2024, the liquidity ratio of SELARL PHARMACIE LEMAITRE... (93.96) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution SELARL PHARMACIE LEMAITRE MALCOTTI
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Operating WCR
141 768 €
136 321 €
0 €
0 €
0 €
0 €
0 €
0 €
0 €
Inventory turnover (days)
27
30
0
0
0
0
0
0
0
Customer payment term (days)
4
2
0
0
0
0
0
0
0
Supplier payment term (days)
62
52
0
0
0
0
0
0
0
Positioning of SELARL PHARMACIE LEMAITRE MALCOTTI in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of SELARL PHARMACIE LEMAITRE MALCOTTI is estimated at
1 783 400 €
(range 1 241 932€ - 2 668 069€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
1241k€1783k€2668k€
1 783 400 €Range: 1 241 932€ - 2 668 069€
NAF 5 année 2024
Valuation method used
Net Income Multiple
127 744 €
×
14.0x
=1 783 401 €
Range: 1 241 932€ - 2 668 069€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELARL PHARMACIE LEMAITRE MALCOTTI with other companies in the same sector:
Frequently asked questions about SELARL PHARMACIE LEMAITRE MALCOTTI
What is the revenue of SELARL PHARMACIE LEMAITRE MALCOTTI ?
The revenue of SELARL PHARMACIE LEMAITRE MALCOTTI in 2017 is 2.1 M€.
Is SELARL PHARMACIE LEMAITRE MALCOTTI profitable?
Yes, SELARL PHARMACIE LEMAITRE MALCOTTI generated a net profit of 128 k€ in 2024.
Where is the headquarters of SELARL PHARMACIE LEMAITRE MALCOTTI ?
The headquarters of SELARL PHARMACIE LEMAITRE MALCOTTI is located in ALLAUCH (13190), in the department Bouches-du-Rhone.
Where to find the tax return of SELARL PHARMACIE LEMAITRE MALCOTTI ?
The tax return of SELARL PHARMACIE LEMAITRE MALCOTTI is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELARL PHARMACIE LEMAITRE MALCOTTI operate?
SELARL PHARMACIE LEMAITRE MALCOTTI operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart